Abstract LB_A12: Initial Results from 2 Phase I Studies of NMS-03305293, a Selective PARP1 Inhibitor
Molecular Cancer Therapeutics(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined